Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

5.4K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
5.4K
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.6K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

2.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.0K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

2.1K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
2.1K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

8.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
8.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Opioid agonist treatment and risk of mortality in French primary care: a nationwide, retrospective cohort study.

The Lancet. Public health·2026
Same author

Measuring performance trajectories in lung cancer surgery: a longitudinal study using the French national hospital database from 2020 to 2024.

BMJ health & care informatics·2026
Same author

Association Between Furosemide and Risk of Parkinson's Disease in a Nested Case-Control Study.

Basic & clinical pharmacology & toxicology·2026
Same author

Reply to "A Comment about AI Methods that May Help Advance Pharmacovigilance".

Clinical pharmacology and therapeutics·2026
Same author

Revisiting the Association Between Calcium Channel Blockers and Parkinson's Disease in the E3N Cohort.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Factors associated with non-participation of preterm infants at two and five years in a large population-based French healthcare network.

BMC pediatrics·2026

Related Experiment Video

Updated: Mar 22, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K

Class-imbalanced subsampling lasso algorithm for discovering adverse drug reactions.

Ismaïl Ahmed1,2,3, Antoine Pariente4,5,6, Pascale Tubert-Bitter1,2,3

  • 11 Inserm UMR 1181, Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases (B2PHI), F-94807 Villejuif, France.

Statistical Methods in Medical Research
|April 27, 2016
PubMed
Summary
This summary is machine-generated.

A novel subsampling method improves pharmacovigilance signal detection by efficiently analyzing spontaneous adverse event reports. This approach reduces false discoveries and enhances the retrieval of known safety signals.

Related Experiment Videos

Last Updated: Mar 22, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K

Area of Science:

  • Pharmacovigilance
  • Biostatistics
  • Data Science

Background:

  • Current pharmacovigilance signal detection relies on aggregated data disproportionality analyses.
  • Individual spontaneous reports can be analyzed using Bayesian lasso logistic regressions, but face computational challenges and parameter selection issues.
  • High-dimensional data in spontaneous reporting present unique challenges for variable selection.

Purpose of the Study:

  • To propose an adapted subsampling method for variable selection in high-dimensional pharmacovigilance data.
  • To address the imbalance and sparsity inherent in spontaneous adverse event reporting.
  • To improve the efficiency and accuracy of safety signal generation.

Main Methods:

  • Adapted Stability Selection using an over-sampling scheme for minority classes (adverse events).
  • Reduced subsample sizes to manage computational load and data imbalance.
  • Compared the proposed method with Stability Selection, gamma-Poisson shrinker, and lasso logistic regression via simulations and empirical study.

Main Results:

  • Simulations demonstrated the proposed sampling strategy yields fewer false discoveries and is faster than standard Stability Selection.
  • Empirical evaluation on the French pharmacovigilance database showed superior performance in retrieving known safety signals compared to existing methods.
  • The method effectively handles large, sparse, and imbalanced spontaneous reporting data.

Conclusions:

  • The proposed subsampling method offers a more efficient and accurate approach to pharmacovigilance safety signal detection.
  • This method enhances the identification of adverse drug reactions from large-scale spontaneous reporting databases.
  • The findings suggest a significant advancement in computational pharmacovigilance methodologies.